ACT and PcbAP for Depression – A Natural Synergy Part 2: The Technical Integration
Harnessing the theoretical and technical synergy between Acceptance and Commitment Therapy (ACT) and Psychedelic Assisted Psychotherapy (PcbAP)
Health - Page 10
The Ayahuasca Afterglow Phenomenon: Exploring Its Significance and Limitations
The afterglow effect is commonly referenced in psychedelic literature. However, limited attention is being paid to several uncontrolled variables.
Ketamine Helps People Dislike Themselves Less
New research shows that ketamine reduces self-dislike, loosening the rigid prejudice toward oneself that can constitute depression.
Examining the Effects of Psychedelics on Experiential Avoidance
Experiential avoidance is one transdiagnostic process that may be implicated in the therapeutic benefits of psychedelics.
Ketamine-Induced Brain Rhythm Causes Dissociation: From Mice to Man
While ketamine produces a whole symphony of effects in the brain, surprisingly, a localized neural oscillation in a lesser-known area of the brain is enough to cause feelings of dissociation.
Psilocybin and Mindfulness for Depression: Complementary Actions Starting to Emerge
Both have long-lasting positive effects on mood, social skills and neuroplasticity. Combining them may potentiate and prolong mutual therapeutic effects.
Psychedelics Improve Depression and Wellbeing Scores in Individuals With Eating Disorders
This study provides the first preliminary quantitative exploration of the psychological effects of psychedelics in individuals with a self-reported diagnosis of an eating disorder.
Food for Thought: Can Psychedelics Boost Brain Growth Factor Levels?
Research suggests that BDNF can help rewire and overwrite stubborn neural pathways by creating new connections that facilitate more flexible and adaptive thoughts and behaviours. Psychedelics appear to tap into this mechanism.
ACT and PcbAP for Depression – A Natural Synergy Part 1: The Theoretical Intersection
Harnessing the theoretical and technical synergy between Acceptance & Commitment Therapy (ACT) and Psilocybin-Assisted Psychotherapy (PcbAP)
Low-Dose LSD Reduces Pain Perception
A new clinical study reports that 20µg of LSD significantly reduces pain perception. This promising investigation builds on the little-known history of research into LSD as a potential analgesic.